E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer
Invasive lobular breast carcinoma (ILC) is defined by loss of the adhesion protein E-cadherin. Using a cancer histology-focused analysis of large-scale drug sensitivity screens, we identify inhibition of the kinase Aurora A as a penetrant synthetic lethal interaction with E-cadherin loss. Combining isogenic cell models, quantitative proteomics, live-cell imaging, patient-derived tumor organoids, and orthotopic xenografts from patients with heavily pre-treated metastatic ILC (mILC), we show that E-cadherin loss alters catenin/Rho/ROCK signaling and imposes a partial defect in centrosomal Aurora A. This defect is normally tolerated but, when exacerbated by pharmacological Aurora A inhibition, causes metaphase arrest and mitotic cell death. Restoring centrosomal Aurora A, or inhibiting ROCK, abolishes this effect. Low tumoral Aurora A is present in most primary lobular tumors. These findings refine the view that high Aurora A expression predicts inhibitor sensitivity and provide the preclinical rationale for trials in mILC.
Authors
- Queenie T. K. Lai (ORCID: https://orcid.org/0000-0002-8423-3631)
- Asha Konde
- Naomi Guppy (ORCID: https://orcid.org/0000-0003-1004-3605)
- Jyoti Sharma Choudhary (ORCID: https://orcid.org/0000-0003-0881-5477)
- Anya A Nicholas (ORCID: https://orcid.org/0009-0005-7482-7443)
- Rachel Brough (ORCID: https://orcid.org/0000-0002-1862-7130)
- Ross Scrimgeour (ORCID: https://orcid.org/0000-0003-1412-9748)
- Clare M. Isacke (ORCID: https://orcid.org/0000-0002-9222-3345)
- Feifei Song (ORCID: https://orcid.org/0000-0001-8571-3111)
- Amanda Fitzpatrick (ORCID: https://orcid.org/0000-0001-9201-3797)
- Cathrin Brisken (ORCID: https://orcid.org/0000-0002-6857-3230)
- Theodoros I. Roumeliotis (ORCID: https://orcid.org/0000-0002-3354-5643)
- Kai B. Betteridge
- Renée L. Flaherty (ORCID: https://orcid.org/0000-0001-5260-965X)
- Stephen J. Pettitt (ORCID: https://orcid.org/0000-0003-3313-3857)
- Andrew N.J. Tutt (ORCID: https://orcid.org/0000-0001-8715-2901)
- Christopher J. Lord (ORCID: https://orcid.org/0000-0002-3226-0515)
- William W. Yang (ORCID: https://orcid.org/0000-0002-6398-4508)
- Chris Starling (ORCID: https://orcid.org/0009-0007-5100-6663)
- Ioannis Roxanis (ORCID: https://orcid.org/0000-0002-0450-2206)
- Solene Pezot (ORCID: https://orcid.org/0009-0000-2741-1545)
- Sarah Meehan
Institutions
- Institute of Cancer Research (GB)
- City, University of London (GB)
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Breast Cancer Now (GB)
- City St George's, University of London (GB)
- École Polytechnique Fédérale de Lausanne (CH)
Publication Details
- Journal
- Cell Reports
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1016/j.celrep.2026.118366
- Primary Topic
- Microtubule and mitosis dynamics
- Type
- article
- Field-Weighted Citation Impact
- 0.00